Polycystic ovary syndrome (PCOS) is a highly familial and heritable endocrine disorder. Over half of the daughters born to women with PCOS may eventually develop their own PCOS-related symptoms. Progress in the treatment of PCOS is currently hindered by the complexity of its clinical manifestations and incomplete knowledge of its etiopathogenesis. Various animal models, including experimentally-induced, naturally-occurring, and spontaneously-arising ones, have been established to emulate a wide range of phenotypical and pathological traits of human PCOS. These studies have led to a paradigm shift for understanding the genetic,developmental, and evolutionary origins of this disorder. Furthermore, emerging evidence suggests that animal models are useful in evaluating state-of-the-art drugs and treatments for PCOS. This review aims to provide a comprehensive summary of recent studies of PCOS in animal models, highlighting the power of these disease models in understanding the biology of PCOS and aiding high-throughput approaches.
Abbott, D.H., Levine, J.E., Dumesic, D.A., 2016. Translational insight into polycystic ovary syndrome (PCOS) from female monkeys with PCOS-like traits. Curr. Pharm. Des. 22, 5625- 5633.
|
Abbott, D.H., Rayome, B.H., Dumesic, D.A., Lewis, K.C., Edwards, A.K., Wallen, K., Wilson, M.E., Appt, S.E., Levine, J.E., 2017. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys. Hum. Reprod. 32, 923-936.
|
Abedal-Majed, M.A., Springman, S.A., Jafar, H.D., Bell, B.E., Kurz, S.G., Wilson, K.E., Cupp, A.S., 2022. Naturally occurring androgen excess cows are present in dairy and beef herds and have similar characteristics to women with PCOS. J. Anim. Sci. 100, skac151.
|
Alfa, R.W., Kim, S.K., 2016. Using Drosophila to discover mechanisms underlying type 2 diabetes. Dis. Model Mech. 9, 365-376.
|
Alzahrani, A.A., Alahmadi, A.A., Ali, S.S., Alahmadi, B.A., Arab, R.A., Wahman, L.F., El-Shitany, N.A., 2019. Biochemical and histological evidence of thyroid gland dysfunction in estradiol valerate model of the polycystic ovary in Wistar rats. Biochem. Biophys. Res. Commun. 514, 194-199.
|
Arifin, E., Shively, C.A., Register, T.C., Cline, J.M., 2008. Polycystic ovary syndrome with endometrial hyperplasia in a cynomolgus monkey (Macaca fascicularis). Vet. Pathol. 45, 512- 515.
|
Azziz, R., 2017. PCOS:Animal models for PCOS-not the real thing. Nat. Rev. Endocrinol. 13, 382-384.
|
Bafor, E.E., Uchendu, A.P., Osayande, O.E., Omoruyi, O., Omogiade, U.G., Panama, E.E., Elekofehinti, O.O., Oragwuncha, E.L., Momodu, A., 2021. Ascorbic acid and Alpha-tocopherol contribute to the therapy of polycystic ovarian syndrome in mouse models. Reprod. Sci. 28, 102-120.
|
Benevides, R.O.A., Vale, C.C., Fontelles, J.L.L., Franca, L.M., Teofilo, T.S., Silva, S.N., Paes, A.M.A., Gaspar, R.S., 2019. Syzygium cumini (L.) Skeels improves metabolic and ovarian parameters in female obese rats with malfunctioning hypothalamus-pituitary-gonadal axis. J.Ovarian Res. 12, 13.
|
Bestetti, I., Barbieri, C., Sironi, A., Specchia, V., Yatsenko, S.A., De Donno, M.D., Caslini, C., Gentilini, D., Crippa, M., Larizza, L., et al., 2021. Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency. Hum.Reprod. 36, 2975-2991.
|
Bishop, C.V., Takahashi, D., Mishler, E., Slayden, O.D., Roberts, C.T., Hennebold, J., True, C., 2021. Individual and combined effects of 5-year exposure to hyperandrogenemia and Western-style diet on metabolism and reproduction in female rhesus macaques. Hum. Reprod. 36, 444-454.
|
Bourgneuf, C., Bailbe, D., Lamaziere, A., Dupont, C., Moldes, M., Farabos, D., Roblot, N., Gauthier, C., Mathieu d'Argent, E., Cohen-Tannoudji, J., et al., 2021. The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome. Nat. Commun. 12, 1064.
|
Caceres, S., Monsalve, B., Alonso-Diez, A., Crespo, B., Illera, M.J., de Andres, P.J., Silvan, G., Illera, J.C., 2021. Blocking estrogen synthesis leads to different hormonal responses in canine and human triple negative inflammatory breast cancer. Cancers (Basel). 13, 4967.
|
Chang, H.M., Qiao, J., Leung, P.C., 2016. Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors. Hum. Reprod.Update. 23, 1-18.
|
Chang, S., Dunaif, A., 2021. Diagnosis of polycystic ovary syndrome:which criteria to use and when? Endocrinol. Metab. Clin. North. Am. 50, 11-23.
|
Chaudhary, H., Patel, J., Jain, N.K., Joshi, R., 2021. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis. J. Ovarian Res. 14, 125.
|
Chen, B., Du, Y.R., Zhu, H., Sun, M.L., Wang, C., Cheng, Y., Pang, H., Ding, G., Gao, J., Tan, Y., et al., 2022a. Maternal inheritance of glucose intolerance via oocyte TET3 insufficiency.Nature. 605, 761-766.
|
Chen, X., Koivuaho, E., Piltonen, T.T., Gissler, M., Lavebratt, C., 2021. Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring:a population-based cohort study. Hum. Reprod. 36, 2345-2357.
|
Chen, Z., Liu, L., Xi, X., Burn, M., Karakaya, C., Kallen, A.N., 2022b. Aberrant H19 expression disrupts ovarian Cyp17 and testosterone production and is associated with polycystic ovary syndrome in women. Reprod. Sci. 29, 1357-1367.
|
Corrie, L., Gulati, M., Singh, S.K., Kapoor, B., Khursheed, R., Awasthi, A., Vishwas, S., Chellappan, D.K., Gupta, G., Jha, N.K., et al., 2021. Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndrome. Life Sci. 280, 119753.
|
Dapas, M., Dunaif, A., 2022. Deconstructing a Syndrome:Genomic Insights Into PCOS Causal Mechanisms and Classification. Endocr. Rev. 43, 927-965.
|
Day, F., Karaderi, T., Jones, M.R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., et al., 2018. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 14, e1007813.
|
di Clemente, N., Racine, C., Pierre, A., Taieb, J., 2021. Anti-Mullerian Hormone in Female Reproduction. Endocr. Rev. 42, 753-782.
|
Dumesic, D.A., Padmanabhan, V., Chazenbalk, G.D., Abbott, D.H., 2022. Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation. Reprod. Biol.Endocrinol. 20, 12.
|
Escobar-Morreale, H.F., 2018. Polycystic ovary syndrome:definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 14, 270-284.
|
Fan, X., Bialecka, M., Moustakas, I., Lam, E., Torrens-Juaneda, V., Borggreven, N.V., Trouw, L., Louwe, L.A., Pilgram, G.S.K., Mei, H., et al., 2019. Single-cell reconstruction of follicular remodeling in the human adult ovary. Nat. Commun. 10, 3164.
|
Fraissinet, A., Robin, G., Pigny, P., Lefebvre, T., Catteau-Jonard, S., Dewailly, D., 2017. Use of the serum anti-Mullerian hormone assay as a surrogate for polycystic ovarian morphology:impact on diagnosis and phenotypic classification of polycystic ovary syndrome. Hum. Reprod. 32, 1716-1722.
|
Franks, S., Stark, J., Hardy, K., 2008. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum. Reprod. Update. 14, 367-378.
|
Garcia-Alonso, L., Lorenzi, V., Mazzeo, C.I., Alves-Lopes, J.P., Roberts, K., Sancho-Serra, C., Engelbert, J., Mareckova, M., Gruhn, W.H., Botting, R.A., et al., 2022. Single-cell roadmap of human gonadal development. Nature. 607, 540-547.
|
Goodarzi, M.O., Carmina, E., Azziz, R., 2015. DHEA, DHEAS and PCOS. J. Steroid Biochem.Mol. Biol. 145, 213-225.
|
Griffin, J., Emery, B.R., Huang, I., Peterson, C.M., Carrell, D.T., 2006. Comparative analysis of follicle morphology and oocyte diameter in four mammalian species (mouse, hamster, pig, and human). J. Exp. Clin. Assist. Reprod. 3, 2.
|
Han, S., Zhang, Y., Zheng, Y., Liu, C., Jiang, Y., Zhao, S., Zhao, H., 2022. Thada is dispensable for female fertility in mice. Front. Endocrinol. (Lausanne). 13, 787733.
|
Harada, M., Takahashi, N., Azhary, J.M., Kunitomi, C., Fujii, T., Osuga, Y., 2021.Endoplasmic reticulum stress:a key regulator of the follicular microenvironment in the ovary.Mol. Hum. Reprod. 27, gaaa088.
|
Ho, E.V., Shi, C., Cassin, J., He, M.Y., Nguyen, R.D., Ryan, G.E., Tonsfeldt, K.J., Mellon, P.L., 2021. Reproductive deficits induced by prenatal antimullerian hormone exposure require androgen receptor in kisspeptin cells. Endocrinology. 162, bqab197.
|
Hwang, J.Y., Lee, E.J., Jin Go, M., Sung, Y.A., Lee, H.J., Heon Kwak, S., Jang, H.C., Soo Park, K., Lee, H.J., Byul Jang, H., et al., 2012. Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition. J. Hum.Genet. 57, 660-664.
|
Islam, H., Masud, J., Islam, Y.N., Haque, F.K.M., 2022. An update on polycystic ovary syndrome:A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options. Womens Health (Lond). 18, 17455057221117966.
|
Jiang, B., Xue, M., Xu, D., Song, J., Zhu, S., 2020. Down-regulated lncRNA HOTAIR alleviates polycystic ovaries syndrome in rats by reducing expression of insulin-like growth factor 1 via microRNA-130a. J. Cell Mol. Med. 24, 451-464.
|
Jiang, K., Zhang, J., Huang, Y., Wang, Y., Xiao, S., Hadden, M.K., Woodruff, T.K., Sun, J., 2021. A platform utilizing Drosophila ovulation for nonhormonal contraceptive screening. Proc.Natl. Acad. Sci. U. S. A. 118, e2026403118.
|
Jiang, Z.Z., Hu, M.W., Ma, X.S., Schatten, H., Fan, H.Y., Wang, Z.B., Sun, Q.Y., 2016. LKB1 acts as a critical gatekeeper of ovarian primordial follicle pool. Oncotarget. 7, 5738-5753.
|
Jonard, S., Robert, Y., Cortet-Rudelli, C., Pigny, P., Decanter, C., Dewailly, D., 2003.Ultrasound examination of polycystic ovaries:is it worth counting the follicles? Hum. Reprod. 18, 598-603.
|
Jones, S.A., Owens, S.L., Birchard, S.J., 2019. Hyperandrogenism associated with an ovarian remnant in a spayed female cat. JFMS. Open Rep. 5, 2055116919885698.
|
Kamada, S., Yamamoto, Y., Aoki, H., Tamura, K., Takeda, A., Minato, S., Masaki, R., Yanagihara, R., Hayashi, N., Yano, Y., et al., 2022. A novel PCOS rat model and an evaluation of its reproductive, metabolic, and behavioral phenotypes. Reprod. Med. Biol. 21, e12416.
|
Karimi, R., Karami, M., Nadoushan, M.J., 2018. Rat's polycystic ovary due to intraventromedial hypothalamus morphine injection. Reprod. Sci. 25, 867-872.
|
Kim, G.J., Mo, H., Liu, H., Wu, Z., Chen, S., Zheng, J., Zhao, X., Nucum, D., Shortland, J., Peng, L., et al., 2021. A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons. eLife. 10, e69795.
|
Kitaeva, K.V., Rutland, C.S., Rizvanov, A.A., Solovyeva, V.V., 2020. Cell culture based in vitro test systems for anticancer drug screening. Front. Bioeng. Biotechnol. 8, 322.
|
Lee, E.B., Chakravarthi, V.P., Wolfe, M.W., Rumi, M.A.K., 2021. ERbeta Regulation of Gonadotropin Responses during Folliculogenesis. Int. J. Mol. Sci. 22, 10348.
|
Li, H., Guo, Y., Zhang, G., Deng, J., Fischer, H., Craig, L.B., Yu, X., Kem, D.C., 2021a.Gonadotrophin-releasing hormone receptor autoantibodies induce polycystic ovary syndrome-like features in a rat model. Exp. Physiol. 106, 902-912.
|
Li, J., Ge, W., 2020. Zebrafish as a model for studying ovarian development:Recent advances from targeted gene knockout studies. Mol. Cell. Endocrinol. 507, 110778.
|
Li, S., Chen, L.N., Zhu, H.J., Feng, X., Xie, F.Y., Luo, S.M., Ou, X.H., Ma, J.Y., 2021b. Single-cell RNA sequencing analysis of mouse follicular somatic cellsdagger. Biol. Reprod. 105, 1234-1245.
|
Li, Z., Li, T., Leng, Y., Chen, S., Liu, Q., Feng, J., Chen, H., Huang, Y., Zhang, Q., 2018.Hormonal changes and folliculogenesis in female offspring of rats exposed to cadmium during gestation and lactation. Environ. Pollut. 238, 336-347.
|
Liu, C., Yue, S., Solarz, J., Lee, J., Li, L., 2021. Improving the sexual activity and reproduction of female zebrafish with high testosterone levels. Sci. Rep. 11, 3822.
|
Liu, H., Li, J., Chang, X., He, F., Ma, J., 2022a. Modeling obesity-associated ovarian dysfunction in Drosophila. Nutrients. 14, 5365.
|
Liu, Q., Zhu, Z., Kraft, P., Deng, Q., Stener-Victorin, E., Jiang, X., 2022b. Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome:a large-scale genome-wide cross-trait analysis. BMC Med. 20, 66.
|
Luo, W., Liu, S., Zhang, W., Yang, L., Huang, J., Zhou, S., Feng, Q., Palli, S.R., Wang, J., Roth, S., et al., 2021. Juvenile hormone signaling promotes ovulation and maintains egg shape by inducing expression of extracellular matrix genes. Proc. Natl. Acad. Sci. U. S. A. 118, e2104461118.
|
Ma, J., He, F., Xie, G., Deng, W.M., 2016. Maternal AP determinants in the Drosophila oocyte and embryo. Wiley Interdiscip. Rev. Dev. Biol. 5, 562-581.
|
Ma, Y., Andrisse, S., Chen, Y., Childress, S., Xue, P., Wang, Z., Jones, D., Ko, C., Divall, S., Wu, S., 2017. Androgen receptor in the ovary theca cells plays a critical role in androgen-induced reproductive dysfunction. Endocrinology. 158, 98-108.
|
Malone, S.A., Papadakis, G.E., Messina, A., Mimouni, N.E.H., Trova, S., Imbernon, M., Allet, C., Cimino, I., Acierno, J., Cassatella, D., et al., 2019. Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism. eLife. 8, e47198.
|
Manti, M., Fornes, R., Pironti, G., McCann Haworth, S., Zhengbing, Z., Benrick, A., Carlstrom, M., Andersson, D., Stener-Victorin, E., 2020. Maternal androgen excess induces cardiac hypertrophy and left ventricular dysfunction in female mice offspring. Cardiovasc. Res. 116, 619-632.
|
McFee, R.M., Romereim, S.M., Snider, A.P., Summers, A.F., Pohlmeier, W.E., Kurz, S.G., Cushman, R.A., Davis, J.S., Wood, J.R., Cupp, A.S., 2021. A high-androgen microenvironment inhibits granulosa cell proliferation and alters cell identity. Mol. Cell Endocrinol. 531, 111288.
|
Mimouni, N.E.H., Paiva, I., Barbotin, A.L., Timzoura, F.E., Plassard, D., Le Gras, S., Ternier, G., Pigny, P., Catteau-Jonard, S., Simon, V., et al., 2021. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab. 33, 513-530.
|
Monniaux, D., Cadoret, V., Clément, F., Dalbies-Tran, R., Elis, S., Fabre, S., Maillard, V., Monget, P., Uzbekova, S., 2019. Folliculogenesis, in:Huhtaniemi, I., Martini, L. (Eds.), Encyclopedia of Endocrine Diseases. Academic Press, Oxford, pp. 377-398.
|
Mu, L., Sun, X., Tu, M., Zhang, D., 2021. Non-coding RNAs in polycystic ovary syndrome:a systematic review and meta-analysis. Reprod. Biol. Endocrinol. 19, 10.
|
Naderpoor, N., Shorakae, S., Abell, S.K., Mousa, A., Joham, A.E., Moran, L.J., Stepto, N.K., Spritzer, P.M., Teede, H.J., de Courten, B., 2018. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome:Relationships with obesity and insulin resistance. J. Steroid Biochem. Mol. Biol. 177, 209-215.
|
Parween, S., Rihs, S., Fluck, C.E., 2020. Metformin inhibits the activation of melanocortin receptors 2 and 3 in vitro:A possible mechanism for its anti-androgenic and weight balancing effects in vivo? J. Steroid Biochem. Mol. Biol. 200, 105684.
|
Peltoketo, H., Zhang, F.P., Rulli, S.B., 2011. Animal models for aberrations of gonadotropin action. Rev. Endocr. Metab. Disord. 12, 245-258.
|
Picard, J.Y., Josso, N., 2019. Persistent Mullerian duct syndrome:an update. Reprod. Fertil.Dev. 31, 1240-1245.
|
Qiao, J., Feng, H.L., 2011. Extra- and intra-ovarian factors in polycystic ovary syndrome:impact on oocyte maturation and embryo developmental competence. Hum. Reprod. Update. 17, 17-33.
|
Racine, C., Genet, C., Bourgneuf, C., Dupont, C., Plisson-Petit, F., Sarry, J., Hennequet-Antier, C., Vigouroux, C., Mathieu d'Argent, E., Pierre, A., et al., 2021. New anti-Mullerian hormone target genes involved in granulosa cell survival in women with polycystic ovary syndrome. J.Clin. Endocrinol. Metab. 106, e1271-e1289.
|
Riquelme, R., Ruz, F., Mayerhofer, A., Lara, H.E., 2021. Huperzine-A administration recovers rat ovary function after sympathetic stress. J. Neuroendocrinol. 33, e12914.
|
Rodriguez Paris, V., Bertoldo, M.J., 2019. The mechanism of androgen actions in PCOS etiology. Med. Sci. (Basel). 7, 89.
|
Rodriguez Paris, V., Solon-Biet, S.M., Senior, A.M., Edwards, M.C., Desai, R., Tedla, N., Cox, M.J., Ledger, W.L., Gilchrist, R.B., Simpson, S.J., et al., 2020. Defining the impact of dietary macronutrient balance on PCOS traits. Nat. Commun. 11, 5262.
|
Rosenfield, R.L., Ehrmann, D.A., 2016. The Pathogenesis of Polycystic Ovary Syndrome(PCOS):The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr.Rev. 37, 467-520.
|
Roy, S., Gandra, D., Seger, C., Biswas, A., Kushnir, V.A., Gleicher, N., Kumar, T.R., Sen, A., 2018. Oocyte-Derived factors (GDF9 and BMP15) and FSH regulate AMH expression via modulation of H3K27AC in granulosa cells. Endocrinology. 159, 3433-3445.
|
Ryu, Y., Kim, Y.J., Kim, Y.Y., Kim, J., Kim, S.W., Kim, H., Ku, S.Y., 2021. Consecutive low doses of streptozotocin induce polycystic ovary syndrome features in mice. Int. J. Mol. Sci. 22, 1299.
|
Saha, P., Kumar, S., Datta, K., Tyagi, R.K., 2021. Upsurge in autophagy, associated with mifepristone-treated polycystic ovarian condition, is reversed upon thymoquinone treatment. J.Steroid Biochem. Mol. Biol. 208, 105823.
|
Santos-Silva, A.P., Andrade, M.N., Pereira-Rodrigues, P., Paiva-Melo, F.D., Soares, P., Graceli, J.B., Dias, G.R.M., Ferreira, A.C.F., de Carvalho, D.P., Miranda-Alves, L., 2018. Frontiers in endocrine disruption:Impacts of organotin on the hypothalamus-pituitary-thyroid axis. Mol.Cell Endocrinol. 460, 246-257.
|
Schoonejans, J.M., Blackmore, H.L., Ashmore, T.J., Pantaleao, L.C., Pellegrini Pisani, L., Dearden, L., Tadross, J.A., Aiken, C.E., Fernandez-Twinn, D.S., Ozanne, S.E., 2022. Sex-specific effects of maternal metformin intervention during glucose-intolerant obese pregnancy on body composition and metabolic health in aged mouse offspring. Diabetologia. 65, 2132- 2145.
|
Schuh, K., Haussler, S., Sadri, H., Prehn, C., Lintelmann, J., Adamski, J., Koch, C., Frieten, D., Ghaffari, M.H., Dusel, G., et al., 2022. Blood and adipose tissue steroid metabolomics and mRNA expression of steroidogenic enzymes in periparturient dairy cows differing in body condition. Sci. Rep. 12, 2297.
|
Serrano Mujica, L.K., Stein, C.S., Miyazato, L.G., Valente, F., Premaor, M.O., Antoniazzi, A.Q., Moresco, R.N., Comim, F.V., 2021. Ovariectomy improves metabolic and oxidative stress marker disruption in androgenized rats:possible approach to postmenopausal polycystic ovary syndrome. Metab. Syndr. Relat. Disord. 19, 312-316.
|
Sharma, A., Laurenti, M.C., Dalla Man, C., Varghese, R.T., Cobelli, C., Rizza, R.A., Matveyenko, A., Vella, A., 2017. Glucose metabolism during rotational shift-work in healthcare workers. Diabetologia. 60, 1483-1490.
|
Sieber, M.H., Thomsen, M.B., Spradling, A.C., 2016. Electron transport chain remodeling by GSK3 during oogenesis connects nutrient state to reproduction. Cell. 164, 420-432.
|
Silber, M., Miller, I., Bar-Joseph, H., Ben-Ami, I., Shalgi, R., 2020. Elucidating the role of pigment epithelium-derived factor (PEDF) in metabolic PCOS models. J. Endocrinol. 244, 297-308.
|
Smet, M.E., McLennan, A., 2018. Rotterdam criteria, the end. Australas J. Ultrasound Med. 21, 59-60.
|
Smith, T., Batur, P., 2021. Prescribing testosterone and DHEA:The role of androgens in women. Cleve. Clin. J. Med. 88, 35-43.
|
Stener-Victorin, E., Padmanabhan, V., Walters, K.A., Campbell, R.E., Benrick, A., Giacobini, P., Dumesic, D.A., Abbott, D.H., 2020. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr. Rev. 41, bnaa010.
|
Swerdloff, R.S., Dudley, R.E., Page, S.T., Wang, C., Salameh, W.A., 2017.Dihydrotestosterone:biochemistry, physiology, and clinical implications of Elevated Blood Levels. Endocr. Rev. 38, 220-254.
|
Tian, Y., Li, J., Su, S., Cao, Y., Wang, Z., Zhao, S., Zhao, H., 2020. PCOS-GWAS Susceptibility variants in THADA, INSR, TOX3, and DENND1A are associated with metabolic syndrome or insulin resistance in women with PCOS. Front. Endocrinol. (Lausanne). 11, 274.
|
Vink, J.M., Sadrzadeh, S., Lambalk, C.B., Boomsma, D.I., 2006. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J. Clin. Endocrinol. Metab. 91, 2100-2104.
|
Wang, R., Liu, X., Li, L., Yang, M., Yong, J., Zhai, F., Wen, L., Yan, L., Qiao, J., Tang, F., 2022. Dissecting human gonadal cell lineage specification and sex determination using a single-cell RNA-seq approach. Genomics Proteomics Bioinformatics. 20, 223-245.
|
Wang, S., Zheng, Y., Li, J., Yu, Y., Zhang, W., Song, M., Liu, Z., Min, Z., Hu, H., Jing, Y., et al., 2020. Single-Cell transcriptomic atlas of primate ovarian aging. Cell. 180, 585-600.
|
Witchel, S.F., Oberfield, S.E., Pena, A.S., 2019. Polycystic ovary syndrome:pathophysiology, presentation, and treatment with emphasis on adolescent girls. J. Endocr. Soc. 3, 1545-1573.
|
Wu, S., Xue, P., Grayson, N., Bland, J.S., Wolfe, A., 2019. Bitter taste receptor ligand improves metabolic and reproductive functions in a murine model of PCOS. Endocrinology. 160, 143- 155.
|
Wu, Y.Y., Li, S.Y., Zhu, H.Q., Zhuang, Z.M., Shao, M., Chen, F.L., Liu, C.S., Tang, Q.F., 2022. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance. J. Ethnopharmacol. 289, 115057.
|
Xu, Y., Gao, Y., Huang, Z., Zheng, Y., Teng, W., Zheng, D., Zheng, X., 2019. LKB1 suppresses androgen synthesis in a mouse model of hyperandrogenism via IGF-1 signaling. FEBS Open Bio. 9, 1817-1825.
|
Yang, Y., Yang, L., Qi, C., Hu, G., Wang, L., Sun, Z., Ni, X., 2020. Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF-kappaB signaling pathway. Mol. Med. Rep. 22, 3851-3861.
|
Yang, Y.L., Zhou, W.W., Wu, S., Tang, W.L., Wang, Z.W., Zhou, Z.Y., Li, Z.W., Huang, Q.F., He, Y., Zhou, H.W., 2021. Intestinal Flora is a key factor in insulin resistance and contributes to the development of polycystic ovary syndrome. Endocrinology. 162, bqab118.
|
Yu, L., Wang, L., Tao, W., Zhang, W., Yang, S., Wang, J., Fei, J., Peng, R., Wu, Y., Zhen, X., et al., 2021. LHCGR and ALMS1 defects likely cooperate in the development of polycystic ovary syndrome indicated by double-mutant mice. J. Genet. Genomics. 48, 384-395.
|
Yue, F., Xing, L., Wu, S., Wei, L., Zhou, Z., Shi, Y., Lam, S.M., Shui, G., Xiang, X., Russell, R., et al., 2022. Constant light exposure alters gut microbiota and short-/medium-chain fatty acids and aggravates PCOS-like traits in HFD-fed rats. Obesity (Silver Spring). 30, 694-706.
|
Zhang, Y., Yan, Z., Qin, Q., Nisenblat, V., Chang, H.M., Yu, Y., Wang, T., Lu, C., Yang, M., Yang, S., et al., 2018. Transcriptome landscape of human folliculogenesis reveals oocyte and granulosa cell interactions. Mol. Cell. 72, 1021-1034.
|
Zhang, Z., Zhu, B., Chen, W., Ge, W., 2020. Anti-Mullerian hormone (Amh/amh) plays dual roles in maintaining gonadal homeostasis and gametogenesis in zebrafish. Mol. Cell Endocrinol. 517, 110963.
|
Zhou, R., Bruns, C.M., Bird, I.M., Kemnitz, J.W., Dumesic, D.A., Abbott, D.H., 2022.Experimentally induced hyperinsulinemia fails to induce polycystic ovary syndrome-like traits in female rhesus macaques. Int. J. Mol. Sci. 23, 2635.
|